FEED
ENvue Medical, Inc.
NASDAQ · Healthcare · Medical - Specialties · US
$3.99
+4.18%Year over year
Reported trailing growth
- Revenue
- -17.7%
- EBITDA
- -75.5%
- EBIT
- -84.8%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +50.3%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- +85.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026